key: cord-0802231-pprsq04q authors: Jouan, Y.; Guillon, A.; Gonzalez, L.; Perez, Y.; Ehrmann, S.; Ferreira, M.; Daix, T.; Jeannet, R.; Francois, B.; Dequin, P.-F.; Si-Tahar, M.; Baranek, T.; Paget, C. title: Functional alteration of innate T cells in critically ill Covid-19 patients date: 2020-05-06 journal: nan DOI: 10.1101/2020.05.03.20089300 sha: ec5726a482dcf29b95f02f724cf9943295429e7d doc_id: 802231 cord_uid: pprsq04q Covid-19 can induce lung infection ranging from mild pneumonia to life-threatening acute respiratory distress syndrome (ARDS). Dysregulated host immune response in the lung is a key feature in ARDS pathophysiology. However, cellular actors in Covid-19-driven ARDS are poorly understood. Here, we dynamically analyzed the biology of innate T cells, a heterogeneous class (MAIT, {gamma}{delta}T and iNKT cells) of T lymphocytes, presenting potent anti-infective and regulatory functions. Patients presented a compartmentalized lung inflammation paralleled with a limited systemic inflammation. Circulating innate T cells of critically ill Covid-19 patients presented a profound and persistent phenotypic and functional alteration. Highly activated innate T cells were detected in airways of patients suggesting a recruitment to the inflamed site and a potential contribution in the regulation of the local inflammation. Finally, the expression of the CD69 activation marker on blood iNKT and MAIT cells at inclusion was predictive of disease severity. Thus, patients present an altered innate T cell biology that may account for the dysregulated immune response observed in Covid-19-related acute respiratory distress syndrome. 19 patients 140 Thirty patients admitted in ICU for severe Covid-19 were included. Baseline characteristics of 141 the patients are presented in Table 1 . Median duration of symptoms before admission in ICU Figure 1A) . 147 Upon enrolment, most of Covid-19 patients (22/30) presented mild to severe lymphopenia (0.75 148 x 10 9 /L ± 0.06) ( Figure 1A ) accompanied by a higher neutrophil-to-lymphocyte ratio as 149 compared to age-and sex-matched controls ( Figure 1B) . As reported 15 , we observed a positive 150 correlation between the degree of lymphopenia and the Sequential Organ Failure Assessment 151 (SOFA) score ( Figure 1C) . Similarly, the lymphopenia was more pronounced in patients under 152 invasive mechanical ventilation as compared to patients who did not require invasive 153 mechanical ventilation ( Figure 1D ). Among the 30 critically ill Covid-19 patients, one died at 154 day 2 after inclusion and 14 (46.7%) were still in ICU at day 15, including 9 still under invasive 155 mechanical ventilation. The remaining 15 patients improved and were discharged from ICU to 156 other wards. 170 airways 171 While a T cell lymphopenia has been described in severe Covid-19 patients 6 , the innate T cell 172 compartment has not been investigated yet. Detailed analysis of circulating iT cells within total 173 T lymphocytes indicated a profound decrease in MAIT (~ 6-fold) and iNKT (~ 7-fold) relative 174 proportions in critically ill Covid-19 patients (Figure 2A ) despite some comorbidities such as 175 obesity and/or diabetes can also partly contribute to this observation 17, 18 . In the meantime, the 176 relative proportion of γδT cells remained unchanged (Figure 2A) . However, by focusing on 177 subsets based on TCR repertoire, we observed that the frequency of Vδ2 + was slightly decreased 178 while the Vδ1δ2cells were increased (Figure 2A) . Of note, no significant differences could be 179 observed for the Vδ1 + subset (Figure 2A) . This may indicate a particular contribution of this 180 γδT subset -likely Vδ3 + -during Covid-19 as suggested in other viral infections 18 . The decrease in circulating MAIT and iNKT cells may have multiple causes. First, we 182 interrogated whether this could be a consequence of activation-induced TCR internalization. Table 1) . We were able to recover cells -containing more than 1% of lymphocytes -in 12 (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 6, 2020. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 6, 2020. . https://doi.org/10.1101/2020.05.03.20089300 doi: medRxiv preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 6, 2020. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 6, 2020. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 6, 2020. Individuals and means ± SEM are shown. ***, p<0.001. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 6, 2020. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 6, 2020. . https://doi.org/10. 1101 /2020 Acute Respiratory Distress Syndrome